Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This trial is designed to compare the effects of twice-daily (before lunch and before dinner)
exenatide plus oral antidiabetic (OAD) agents and twice-daily (before breakfast and before
dinner) exenatide plus OAD with respect to glycemic control (HbA1c) in patients with type 2
diabetes.